Formulation and Evaluation of Taste-Masked Levocetirizine Dihydrochloride Orally Disintegrating Tablets

References

1. 1.↵
   1. Virely P.,
   2. Yarwood R.

   Zydis—A novel, fast dissolving dosage form. Manuf. Chem. 1999, 61 ( 2), 36– 37.

   OpenUrl
2. 2.↵
   1. Sastry S. V.,
   2. Nyshadham J. R.,
   3. Fix J. A.

   Recent technological advances in oral drug delivery—a review. Pharmaceutical Science & Technology Today 2000, 3 ( 4), 138– 145.

   OpenUrlPubMed
3. 3.↵
   1. Tillement J.,
   2. Testa B.,
   3. Bree F.

   Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H₁-receptor antagonists. Biochemical Pharmacology 2003, 66 ( 7), 1123– 1126.

   OpenUrlPubMed
4. 4.↵
   1. Simons E. R.,
   2. Gortiz S. S.,
   3. Simons K. J.

   Clinical pharmacology of levocetirizine, the active enantiomer of cetirizine, in children age 6–11 years. J. Allergy Clin. Immunology 2005, 115 ( 2), 355– 361.

   OpenUrl
5. 5.↵
   1. Dorfner K.

   Ion Exchanger Properties and Applications, 3rd edition. Ann Arbor Science Publishers, Inc,: Ann Arbor, MI, 1972; p. 2.
6. 6.↵
   1. Borodkin S.,
   2. Sunderberg D. P.

   Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin. Patent US 3,594,470, 1971.
7. 7.↵
   1. Sohi H.,
   2. Sultana Y.,
   3. Khar R. K.

   Taste Masking Technologies in Oral Pharmaceuticals: Recent Developments and Approaches. Drug Development and Industrial Pharmacy 2004, 30 ( 5), 429– 448.

   OpenUrlPubMed
8. 8.↵
   1. Choudhari P. D.,
   2. Colhe S. R.,
   3. Choudhari S. P.,
   4. More D. M.

   Use of ion-exchange resins to optimize the taste masking of bitter drug rizatriptan benjoate. Indian Drugs 2006, 43 ( 10).
9. 9.↵
   1. Matoba H.,
   2. Ohmori S.,
   3. Koyama H.,
   4. Kashihara T.

   Solid Preparation Comprising Ion Exchanger and Active Agent. US Patent 5,464,612, November 7, 1995.
10. 10.↵
    1. Agarwall R.,
    2. Mittal R.,
    3. Singh A.

    Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev. Ind. Pharm. 2000, 26 ( 7), 773– 776.

    OpenUrlPubMed
11. 11.↵
    1. Klancke J.

    Dissolution testing of orally disintegrating tablets. Dissolution Technologies 2003, 10 ( 2).
12. 12.↵
    1. Aly A.,
    2. Semreen M.,
    3. Qato M.

    Superdisintegrants for solid dispersion: To produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharmaceutical Technology 2005, 29 ( 1), 68– 78.

    OpenUrl
13. 13.↵
    1. Nakamura T.,
    2. Tanigake A.,
    3. Miyananga Y.,
    4. Ogawa T.,
    5. Akiyoshi T.,
    6. Matsuyama K.,
    7. Uchida T.

    The effect of various substances on the suppression of the bitterness of quinine-human gustatory sensation, binding, and taste sensor studies. Chem. Pharm. Bull. 2002, 50 ( 12), 1589– 1593.

    OpenUrlPubMed
14. 14.↵
    Thermax Ion-Exchange resin, Information brochure.
15. 15.↵
    1. Nanda A.,
    2. Kandarapu R.,
    3. Garg S.

    An update on taste masking technologies for oral pharmaceuticals. Indian J. Pharm. Sci. 2002, 64 ( 1), 10– 17.

    OpenUrl
16. 16.↵
    1. Cotterill J. V.,
    2. Massie G.,
    3. Cowan D. P.

    Masking the taste of the conditioned taste aversion agent levamisole using an ion-exchange resin, for practical application in wildlife management. Pest Manag. Sci. 2006, 62 ( 2), 120– 125.

    OpenUrlPubMed
17. 17.↵
    Pharmaceutical technical bulletin, Poly plasdone XL-10, New Jersey, USA.